Treatment of reserpine-induced depression with a new analeptic: phenidylate.
D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D003863:Depression / Q000209:etiology*; D003866:Depressive Disorder; D001523:Mental Disorders / Q000628:therapy*; D008774:Methylphenidate; D010880:Piperidines / Q000494:pharmacology*; D011613:Psychotherapy; D012110:Reserpine; D046948:Secologanin Tryptamine Alkaloids / Q000009:adverse effects*
D000697:Central Nervous System Stimulants; D010880:Piperidines; D046948:Secologanin Tryptamine Alkaloids; D008774:Methylphenidate; D012110:Reserpine
ANALEPTICS/effects; DEPRESSION/etiology and pathogenesis; MENTAL DISORDERS/therapy; PIPERIDINES/effects; RAUWOLFIA ALKALOIDS/injurious effects